Maxcyte (MXCT) Income towards Parent Company (2020 - 2026)
Maxcyte (MXCT) reported Income towards Parent Company of -$4.8 million for Q1 2026, up 53.71% year-over-year from -$3.1 million in Q1 2025, and up 50.5% on a QoQ basis from -$9.6 million in Q4 2025.
Maxcyte (MXCT) has 7 years of Income towards Parent Company data on file, last reported at -$4.8 million in Q1 2026.
- Quarterly Income towards Parent Company rose 53.71% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39.1 million (up 6.39% YoY) and the FY2025 annual result came in at -$44.6 million, down 8.71% from the prior year.
- Income towards Parent Company advanced to -$4.8 million in Q1 2026 per MXCT's latest filing, from -$9.6 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$4.1 million in Q1 2022 and bottomed at -$12.4 million in Q3 2025.
- The 5-year median for Income towards Parent Company is -$9.6 million (2025), against an average of -$8.9 million.
- The widest annual swing landed in 2023, when Income towards Parent Company slumped 167.55%; it then soared 53.71% in 2026.
- Tracing MXCT's Income towards Parent Company over 5 years: stood at -$4.8 million in 2022, then decreased by 9.74% to -$5.3 million in 2023, then tumbled by 100.78% to -$10.6 million in 2024, then climbed by 9.45% to -$9.6 million in 2025, then jumped by 50.5% to -$4.8 million in 2026.
- Per Business Quant, the three latest MXCT Income towards Parent Company figures stand at -$4.8 million (Q1 2026), -$9.6 million (Q4 2025), and -$12.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.75 Mn |
| Dec 31, 2025 | -9.60 Mn |
| Sep 30, 2025 | -12.42 Mn |
| Jun 30, 2025 | -12.36 Mn |
| Mar 31, 2025 | -10.26 Mn |
| Dec 31, 2024 | -10.60 Mn |
| Sep 30, 2024 | -11.56 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -9.53 Mn |
| Dec 31, 2023 | -5.28 Mn |
| Sep 30, 2023 | -11.25 Mn |
| Jun 30, 2023 | -10.51 Mn |
| Mar 31, 2023 | -10.88 Mn |
| Dec 31, 2022 | -4.81 Mn |
| Sep 30, 2022 | -6.43 Mn |
| Jun 30, 2022 | -8.26 Mn |
| Mar 31, 2022 | -4.07 Mn |
| Dec 31, 2021 | -4.87 Mn |
| Sep 30, 2021 | -2.68 Mn |
| Jun 30, 2021 | -4.42 Mn |
| Mar 31, 2021 | -7.11 Mn |
| Dec 31, 2020 | 5.92 Mn |
| Sep 30, 2020 | -3.10 Mn |
| Jun 30, 2020 | -3.00 Mn |